Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women
Paul M. Ridker(Brigham and Women's Hospital), Julie E. Buring(Brigham and Women's Hospital), Nader Rifai(Boston Children's Hospital), I‐Min Lee(Brigham and Women's Hospital), M. Vinayaga Moorthy(Brigham and Women's Hospital), Nancy R. Cook(Brigham and Women's Hospital)
Cited by 246
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Markers of Inflammation and Cardiovascular Disease
|Circulation|2003|6.3k
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
|New England Journal of Medicine|2002|3.6k
Atherosclerosis
|Nature Reviews Disease Primers|2019|3k